Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) is associated with viral malignancy, related to HIV-AIDS. With a wide geographical discrimination in its occurrence, Asian countries shows low to moderate prevalence with higher occurrence in some particular areas. India is one of the largest countries in Asia, having various geographical and cultural variations where KSHV has been considered as an unthinkable entity to cause any of its associated disease. India has been reported as a low prevalent zone for KSHV malignancy till date. Also there are no reports so far, describing the occurrence pattern of this malignancy. So this review approaches towards figuring out the tendency of prevalence pattern of this malignancy and associated risk factors found to be present in Indian population. From this study it is revealed that, KSHV related malignancy is a relatively newly reported and emerging disease in India and may exist in hidden pockets throughout India in association with tuberculosis. India shows prevalence in HIV-associated Kaposi’s sarcoma in regions where socially discriminated LGBT (lesbian, gay, bisexual, and transgender) groups, unprotected sexual behavior and heterosexuality are the important risk factors for sexually transmitted viral diseases. Anti-retro viral therapy is not sufficient to combat the virus and may act adversely. On a note regarding the clinical representations of Kaposi’s sarcoma, oral, mucosal, pleural and abdominal involvements are observed in worst cases and these can be considered as the main manifesting criteria for this malignancy among Indians.


Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer. 1999;81(5):893–7. https://doi.org/10.1038/sj.bjc.6690782.
Acharya VK, Rai S, Shirgavi S, Pai RR, Anand R. Multicentric castleman’s disease: “A rare entity that mimics malignancy”. Lung India Off Organ Indian Chest Soc. 2016;33(6):689–91. https://doi.org/10.4103/0970-2113.192864.
Agarwala MK, George R, Sudarsanam TD, Chacko RT, Thomas M, Nair S. Clinical course of disseminated Kaposi sarcoma in a HIV and hepatitis B co-infected heterosexual male. Indian Dermatol Online J. 2015;6(4):280–3. https://doi.org/10.4103/2229-5178.160271.
Al-Dayel A, Guella A, Alzahrani AJ, et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant. 2005;20(11):2532–6. https://doi.org/10.1093/ndt/gfi058.
Altuglu I, Yolcu A, Ocek ZA, Yazan Sertoz R, Gokengin D. Investigation of human herpesvirus-8 seroprevalence in blood donors and HIV-positive patients admitted to Ege University Medical School Hospital, Turkey. Mikrobiyoloji bulteni. 2016;50(1):104–11.
Arul AS, Kumar AR, Verma S, Arul AS. Oral Kaposi’s sarcoma: sole presentation in HIV seropositive patient. J Nat Sci Biolmed. 2015;6(2):459–61. https://doi.org/10.4103/0976-9668.160041.
Ascoli V, Senis G, Zucchetto A, et al. Distribution of ‘promoter’ sandflies associated with incidence of classic Kaposi’s sarcoma. Med Vet Entomol. 2009;23(3):217–25. https://doi.org/10.1111/j.1365-2915.2009.00811.x.
Behera B, Chandrashekar L, Thappa DM, Toi P, Vinod KV. Disseminated Kaposi’s sarcoma in an HIV-positive patient: a rare entity in an Indian patient. Indian J Dermatol. 2016;61(3):348. https://doi.org/10.4103/0019-5154.182466.
Bhagat U, Sharma A, Marfatia YS. Violaceous papulonodular lesions in an AIDS case. Indian J Sex Transm Dis AIDS. 2008;29:51–3.
Bhatia R, Shubhdarshini S, Yadav S, Ramam M, Agarwal S. Disseminated Kaposi’s sarcoma in a human immunodeficiency virus-infected homosexual Indian man. Indian J Dermatol Venereol Leprol. 2017;83(1):78–83. https://doi.org/10.4103/0378-6323.193612.
Blumenthal MJ, Schutz C, Barr D, et al. The contribution of Kaposi’s sarcoma-associated herpesvirus to mortality in hospitalized human immunodeficiency virus-infected patients being investigated for tuberculosis in South Africa. J Infect Dis. 2019;220(5):841–51. https://doi.org/10.1093/infdis/jiz180.
Castro A, Pedreira J, Soriano V, et al. Kaposi’s sarcoma and disseminated tuberculosis in HIV-negative individual. Lancet. 1992;339(8797):868.
Chandan K, Madnani N, Desai D, Deshpande R. AIDS-associated Kaposi’s sarcoma in a heterosexual male—a case report. Dermatol Online J. 2002;8(2):19.
Chatlynne LG, Ablashi DV. Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol. 1999;9(3):175–85. https://doi.org/10.1006/scbi.1998.0089.
Chen YJ, Shieh PP, Shen JL. Orificial tuberculosis and Kaposi’s sarcoma in an HIV-negative individual. Clin Exp Dermatol. 2000;25(5):393–7.
Conant K, Kaleeba J. Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi’s sarcoma and P. falciparum malaria. Front Microbiol. 2013. https://doi.org/10.3389/fmicb.2013.00035.
Dhote A, Umap P, Shrikhande A. Fine needle cytology of Kaposi’s sarcoma in heterosexual male. Int J Res Med Sci. 2014;2(2).
Dilnur P, Katano H, Wang ZH, et al. Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int. 2001;51(11):845–52.
Dongre A, Montaldo C. Kaposi’s sarcoma in an HIV-positive person successfully treated with paclitaxel. Indian J Dermatol Venereol Leprol. 2009;75(3):290–2. https://doi.org/10.4103/0378-6323.51254.
Erickson AK, Jesudhasan PR, Mayer MJ, Narbad A, Winter SE, Pfeiffer JK. Bacteria facilitate enteric virus co-infection of mammalian cells and promote genetic recombination. Cell Host Microbe. 2018;23(1):7788.e5. https://doi.org/10.1016/j.chom.2017.11.007.
Gatphoh ED, Zamzachin G, Devi SB, Punyabati P. AIDS related malignant disease at regional institute of medical sciences. Indian J Pathol Microbiol. 2001;44(1):1–4.
Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R. Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS. 2017;12(1):47–56. https://doi.org/10.1097/COH.0000000000000330.
Gopala A, V Ramana Reddy G. Kaposi’s sarcoma in a follow-up patient of malignant schwannoma after seroconversion. Indian J Surg. 2004;66:110–2.
Gowda NM, Wu X, Kumar S, Febbraio M, Gowda DC. CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells. PLoS ONE. 2013;8(10):e77604. https://doi.org/10.1371/journal.pone.0077604.
Ismail SI, Mahmoud IS, Salman MA, Sughayer MA, Mahafzah AM. Frequent detection of human herpes virus-8 in bone marrow of Jordanian patients of multiple myeloma. Cancer Epidemiol. 2011;35(5):471–4. https://doi.org/10.1016/j.canep.2010.10.006.
Jakob L, Metzler G, Chen K-M, Garbe C. Non-AIDS associated Kaposi’s sarcoma: clinical features and treatment outcome. PLoS ONE. 2011;6(4):e18397. https://doi.org/10.1371/journal.pone.0018397.
Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi’s sarcoma in Iran. Infect Agents Cancer. 2011;6:5. https://doi.org/10.1186/1750-9378-6-5.
Jan RA, Koul PA, Ahmed M, Shah S, Mufti SA, War FA. Kaposi sarcoma in a non HIV patient. Int J Health Sci. 2008;2(2):153–6.
Jethwani KS, Mishra SV, Jethwani PS, Sawant NS. Surveying Indian gay men for coping skills and HIV testing patterns using the internet. J Postgrad Med. 2014;60(2):130–4. https://doi.org/10.4103/0022-3859.132315.
Joshi U, Ceena DE, Ongole R, et al. AIDS related Kaposi’s sarcoma presenting with palatal and eyelid nodule. J Assoc Phys India. 2012;60:50–3.
Karass M, Grossniklaus E, Seoud T, Jain S, Goldstein DA. Kaposi sarcoma inflammatory cytokine syndrome (KICS): a rare but potentially treatable condition. Oncologist. 2017;22(5):623–5. https://doi.org/10.1634/theoncologist.2016-0237.
Karim QA. Current status of the HIV epidemic & challenges in prevention. Indian J Med Res. 2017;146(6):673–6. https://doi.org/10.4103/ijmr.IJMR_1912_17.
Kharkar V, Gutte RM, Khopkar U, Mahajan S, Chikhalkar S. Kaposi’s sarcoma: a presenting manifestation of HIV infection in an Indian. Indian J Dermatol Venereol Leprol. 2009;75(4):391–3. https://doi.org/10.4103/0378-6323.53137.
Kodra A, Walczyszyn M, Grossman C, Zapata D, Rambhatla T, Mina B. Case report pulmonary Kaposi sarcoma in a non-HIV patient. F1000Research. 2015;4:1013. https://doi.org/10.12688/f1000research.7137.1.
Kumarasamy N, Solomon S, Yesudian PK, Sugumar P. First report of Kaposi’s sarcoma in an AIDS patient from Madras. India. Indian J Dermatol. 1996;41(1):23–5.
Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The world-wide incidence of Kaposi’s sarcoma in the HIV/AIDS era. HIV Med. 2018;19(5):355–64. https://doi.org/10.1111/hiv.12584.
Manion M, Uldrick T, Polizzotto MN, et al. Emergence of Kaposi’s sarcoma herpesvirus-associated complications following corticosteroid use in TB-IRIS. Open Forum Infect Dis. 2018;5(10):ofy217. https://doi.org/10.1093/ofid/ofy217.
Margalith M, Chatlynne LG, Fuchs E, et al. Human herpesvirus 8 infection among various population groups in southern Israel. J Acquir Immune Defic Syndr. 2003;34(5):500–5.
McArdle AJ, Turkova A, Cunnington AJ. When do co-infections matter? Curr Opin Infect Dis. 2018;31(3):209–15. https://doi.org/10.1097/QCO.0000000000000447.
Mehta S, Garg A, Gupta LK, Mittal A, Khare AK, Kuldeep CM. Kaposi’s sarcoma as a presenting manifestation of HIV. Indian J Sex Transm Dis AIDS. 2011;32(2):108–10. https://doi.org/10.4103/0253-7184.85415.
Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516–23. https://doi.org/10.1016/s1473-3099(08)70184-1.
Modak D, Ganguly RR, Haldar SN, Samanta PS, Pramanik N, Guha SK. Castlemans disease in HIV infected patient from eastern India. J Assoc Phys India. 2008;56:547–8.
Mukherjee S. Emerging infectious diseases: epidemiological perspective. Indian J Dermatol. 2017;62(5):459–67. https://doi.org/10.4103/ijd.IJD_379_17.
Munawwar A, Sharma SK, Gupta S, Singh S. Seroprevalence and determinants of Kaposi sarcoma-associated human herpesvirus 8 in Indian HIV-infected males. AIDS Res Hum Retroviruses. 2014;30(12):1192–6. https://doi.org/10.1089/aid.2014.0184.
Paranjape RS, Challacombe SJ. HIV/AIDS in India: an overview of the Indian epidemic. Oral Dis. 2016;22(S1):10–4. https://doi.org/10.1111/odi.12457.
Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ. Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol. 2009;19(8):597–601. https://doi.org/10.1016/j.annepidem.2009.04.002.
Perez-Alvarez S, Benavente Y, de Sanjose S, et al. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis. 2009;199(10):1449–56. https://doi.org/10.1086/598523.
Potsangbam G, Surchandra Sharma S, Singh TJ, et al. Intra-lesional injection of vinblastine in a pedunculated oral Kaposi’s sarcoma in a patient of AIDS. JIACM. 2007;8(1):99–100.
Qin J, Lu C. Infection of KSHV and interaction with HIV: the bad romance. Adv Exp Med Biol. 2017;1018:237–51. https://doi.org/10.1007/978-981-10-5765-6_15.
Sarmati L, Andreoni M, Suligoi B, et al. Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. Am J Trop Med Hyg. 2003;68(4):501–2.
Sarov B, Davidovici B, Boshoff C, et al. Seroepidemiology and molecular epidemiology of Kaposi’s sarcoma-associated herpesvirus among jewish population groups in Israel. JNCI J Natl Cancer Inst. 2001;93(3):194–202. https://doi.org/10.1093/jnci/93.3.194.
Sehgal VN, Verma P, Sharma S. HIV/AIDS Kaposi sarcoma: the Indian perspective. Skinmed. 2013;11(6):375–7.
Sharma RK, Bhardwaj S. Kaposi sarcoma presenting as an index sign of HIV infection in an Indian. JK Sci. 2012;14(3):158–60.
Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspect Med. 2011;1(1):a006841-a41. https://doi.org/10.1101/cshperspect.a006841.
Shenoy VV, Joshi SR, Duberkar D, Kadam KN, Shedge RT, Lanjewar DN. Kaposi’s sarcoma with thrombocytopenia in a heterosexual Asian Indian male. J Assoc Phys India. 2005;53:486–8.
Shroff HJ, Dashatwar DR, Deshpande RP, Waigmann HR. AIDS-associated Kaposi’s sarcoma in an Indian female. J Assoc Phys India. 1993;41(4):241–2.
Simonart T. Iron: a target for the management of Kaposi’s sarcoma? BMC Cancer. 2004;4(1):1. https://doi.org/10.1186/1471-2407-4-1.
Simonart T. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Cancer Lett. 2006;244(1):1–7. https://doi.org/10.1016/j.canlet.2006.02.005.
Sinha A, Goswami D, Haldar D, Mallik S, Bisoi S, Karmakar P. Sexual behavior of transgenders and their vulnerability to HIV/AIDS in an Urban Area of Eastern India. Indian J Public Health. 2017;61(2):141–3. https://doi.org/10.4103/ijph.IJPH_248_14.
Solomon S, Solomon SS, Ganesh AK. AIDS in India. Postgrad Med J. 2006;82(971):545–7. https://doi.org/10.1136/pgmj.2006.044966.
Su CC, Lai CL, Tsao SM, et al. High prevalence of human herpesvirus type 8 infection in patients with pulmonary tuberculosis in Taiwan. Clin Microbiol Infect. 2015;21(3):266.e5–7. https://doi.org/10.1016/j.cmi.2014.10.015.
Sunil M, Reid E, Lechowicz MJ. Update on HHV-8-associated malignancies. Curr Infect Dis Rep. 2010;12(2):147–54. https://doi.org/10.1007/s11908-010-0092-5.
Thakker S, Verma SC. Co-infections and pathogenesis of KSHV-associated malignancies. Front Microbiol. 2016;7:151. https://doi.org/10.3389/fmicb.2016.00151.
The LancetH. Homosexuality law reform is just a first step for India. The lancet. HIV. 2018;5(10):e537. https://doi.org/10.1016/s2352-3018(18)30260-1.
V Singh R, Singh S, Pandey S. . Numerous giant mollusca contagiosa and Kaposi’s sarcomas with HIV disease. Indian J Dermatol Venereol Leprol. 1996;62(3):173–4.
Vaishnani JB, Bosamiya SS, Momin AM. Kaposi’s sarcoma: a presenting sign of HIV. Indian J Dermatol Venereol Leprol. 2010;76(2):215. https://doi.org/10.4103/0378-6323.60542.
Verma SC, Robertson ES. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett. 2003;222(2):155–63. https://doi.org/10.1016/S0378-1097(03)00261-1.
Wakeham K, Webb EL, Sebina I, et al. Parasite infection is associated with Kaposi’s sarcoma associated herpesvirus (KSHV) in Ugandan women. Infect Agents Cancer. 2011;6(1):15. https://doi.org/10.1186/1750-9378-6-15.
Wang X, Zou Z, Deng Z, et al. Male hormones activate EphA2 to facilitate Kaposi’s sarcoma-associated herpesvirus infection: implications for gender disparity in Kaposi’s sarcoma. PLoS Pathog. 2017;13(9):e1006580. https://doi.org/10.1371/journal.ppat.1006580.
Warpe BM. Kaposi sarcoma as initial presentation of HIV infection. N Am J Med Sci. 2014;6(12):650–2. https://doi.org/10.4103/1947-2714.147984.
Zhang T, Wang L. Epidemiology of Kaposi’s sarcoma-associated herpesvirus in Asia: challenges and opportunities. J Med Virol. 2017;89(4):563–70. https://doi.org/10.1002/jmv.24662.
Zhang T, Shao X, Chen Y, et al. Human herpesvirus 8 seroprevalence, China. Emerg Infect Dis. 2012;18(1):150–2. https://doi.org/10.3201/eid1801.102070.
Acknowledgements
We would like to thank Mr. LaltuHazra, regarding his general laboratory help and CSIR for their financial assistance byCSIR SRF fellowship (Council of Scientific and Industrial Research, Govt. of India, Senior Research Fellowship).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary fig. 1
Overallcharacterization of Indian KSHV associated malignancy (TIFF 1038 kb)
Rights and permissions
About this article
Cite this article
Das, P., Chattopadhyay, N.R., Chatterjee, K. et al. Kaposi’s sarcoma-associated herpesvirus related malignancy in India, a rare but emerging member to be considered. VirusDis. 31, 209–219 (2020). https://doi.org/10.1007/s13337-020-00573-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13337-020-00573-3
